Navigation Links
Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
Date:11/2/2011

stralia following issuances in Europe and the United States. This further exemplifies Regulus' leading intellectual property portfolio in the field of microRNA therapeutics. Recent clinical data in the field has demonstrated that inhibiting miR-122 with an oligonucleotide is safe, well tolerated, and able to reduce viral titers. That data, in combination with Regulus' data demonstrating potent inhibition with a proprietary anti-miR having favorable pharmacokinetic properties, supports the development of anti-miR-122 for the treatment of HCV in combination with other anti-virals," said Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus Therapeutics. "The HCV landscape has undergone a tremendous amount of transformation with the recent emergence of new direct-acting antivirals.  Anti-miR-122 is attractively positioned because it targets a host factor that is essential for viral replication and therefore may be resistant to viral mutation and escape."

miR-122 is a liver-expressed microRNA that has been shown to be a critical endogenous "host factor" for the replication of HCV, and anti-miRs targeting miR-122 have been shown to block HCV infection (Jopling et al. (2005) Science 309, 1577-81). In earlier work, scientists at Alnylam Pharmaceuticals and Isis Pharmaceuticals (Regulus' co-founders) demonstrated the ability to antagonize miR-122 in vivo using chemically modified single-stranded anti-miR oligonucleotides. Data from multiple preclinical studies have shown a robust HCV antiviral effect following inhibition of miR-122.  In February 2010, Regulus and GlaxoSmithKline entered into a new collaboration to develop and commercialize microRNA therapeutics targeting microRNA-122 for the treatment of hepatitis C infection.

Regulus is advancing multiple other microRNA therapeutic programs to the clinic in the areas of fibrosis, immuno-inflammatory disease, metabolic disease, and oncology.

'/>"/>
SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis
2. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
3. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
4. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
5. Echo Therapeutics Announces Warrant Exercise by Its Largest Shareholder
6. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
7. Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform
8. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
9. Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
10. Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11. Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... España, July 4, 2015 ... la quimioterapia de primera línea para pacientes con ... (mCRC) extiende la supervivencia libre de progresión en ... colorrectal metastásico no resecable (mCRC) que se ha ... en la supervivencia libre de progresión (PFS) en ...
(Date:7/4/2015)... July 4, 2015 ... eerstelijns chemotherapie voor patiënten met niet-resectabele uitgezaaide ... de progressievrije overleving in dat orgaan. ... kanker (mCRC) die alleen binnen de lever ... progressievrije overleving (PFS) in de lever dankzij ...
(Date:7/4/2015)... 2015 Adding SIR-Spheres® Y-90 ... unresectable metastatic colorectal cancer in the liver (mCRC) ... Patients with unresectable metastatic colorectal cancer (mCRC) ... the greatest improvement in Progression-Free Survival (PFS) in ... resin microspheres to a current first-line chemotherapy regimen, ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... Chronic Neck ... of chronic pain sufferers have pain located in the neck. Another 19% suffer from ... neck. Chiropractic literature suggests that 45% of American workers must deal with ...
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... When a hacker gains access to ... front and at the office. On Wednesday, July 1st, the FTC issued a scam ... as part of a verification process for a password reset instigated by the hacker. ...
(Date:7/4/2015)... , ... July 04, 2015 , ... ... solar industry’s leading recognition of technical sales expertise from the North American Board ... Sales ProfessionalTM. NABCEP is the most highly respected and well established national certification ...
(Date:7/3/2015)... ... ... Harvest Hope Food Bank will hopefully be getting a large donation of canned food ... of Greenville SC are making it their mission to collect as many canned items as ... donations from the public as well. As part of the canned food drive, these local ...
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon ... 2nd creating a buzz of media attention. In an effort to spread the ... Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress and ...
Breaking Medicine News(10 mins):Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... Nov. 6 Cogdell Spencer Inc.,(NYSE: CSA ... invests in,specialty office buildings, including medical offices and ... and,design-build services for the medical profession, today announced ... Third Quarter 2008 Results, Cogdell Spencer ...
... Positive approaches more likely to prompt minorities to get ... (HealthDay News) -- Cancer-screening messages targeted to minorities that ... colon cancer is a bigger threat to blacks than ... be screened, a new study found. , "There have ...
... MVP Health Care, a leading,regional not-for-profit health ... Vermont and New Hampshire, has selected IncentOne, the ... to MVP and,Preferred Care health plan members through ... Care health plans that utilize the "WellStyle Extras",option, ...
... directly slow down HIV infection by targeting the reverse ... JBC . This beneficial effect does pose a risk ... emergence of multi-drug resistant HIV variants. , HIV ... sexually transmitted diseases worldwide, and individuals frequently become co-infected ...
... as Company Prepares to Publish Unique ... Pre- & Post-Accident Study ... improve diagnosis of,returning military personnel for traumatic brain injuries, three leading,military ... Naval Hospital at Camp Pendleton in California and Tripler Army,Medical Center ...
... associated with use of Avandia, urges FDA commissioner to remove ... ... Mineola, N.Y. (Lexis Nexis) November 6, 2008 -- Public ... has petitioned the Commissioner of the U.S. Food and Drug ...
Cached Medicine News:Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 2Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 3Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 4Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 5Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 6Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 7Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 8Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 9Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 10Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 11Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 12Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 13Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 14Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 15Health News:Cogdell Spencer Inc. Reports Third Quarter 2008 Financial Results 16Health News:Negative Cancer Messages Backfire With Blacks 2Health News:MVP Health Care and IncentOne Partner to Provide Member Incentives for MVP and Preferred Care 'WellStyle Extras' Program 2Health News:Walter Reed Army Medical Center, Naval Hospital Camp Pendleton & Tripler Army Medical Center to Install Neuro Kinetics' I-Portal(R) NOTC System for Traumatic Brain Injury Testing 2Health News:Public Citizen Petitions FDA to Ban Diabetes Drug Avandia, According to Avandia Plaintiffs Attorney Group 2
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
... Elite System™ and USA ... utilized for incision of ... neck contractures under direct ... converts the visual urethrotome ...
... USA Elite System™ and ... are utilized for incision ... bladder neck contractures under ... obturator converts the visual ...
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
Medicine Products: